Thomas Sciascia
2023
In 2023, Thomas Sciascia earned a total compensation of $977.1K as Chief Scientific Officer at Trevi Therapeutics, a 69% increase compared to previous year.
Compensation breakdown
| Bonus | $117,600 |
|---|---|
| Option Awards | $425,699 |
| Salary | $424,677 |
| Other | $9,149 |
| Total | $977,125 |
Sciascia received $425.7K in option awards, accounting for 44% of the total pay in 2023.
Sciascia also received $117.6K in bonus, $424.7K in salary and $9.1K in other compensation.
Rankings
In 2023, Thomas Sciascia's compensation ranked 1,222nd out of 2,878 executives tracked by ExecPay. In other words, Sciascia earned more than 57.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,222 out of 2,878 | 58th |
Division Manufacturing | 729 out of 1,582 | 54th |
Major group Chemicals And Allied Products | 487 out of 891 | 45th |
Industry group Drugs | 475 out of 854 | 44th |
Industry Pharmaceutical Preparations | 327 out of 614 | 47th |
Source: SEC filing on April 26, 2024.
Sciascia's colleagues
We found two more compensation records of executives who worked with Thomas Sciascia at Trevi Therapeutics in 2023.